
Here's a free copy of Make Better Decisions, the course text for our other course on Pharmaceutical Business Intelligence. Enjoy!
Explore how drug development progresses from discovery to commercialization, identifying lead compounds, conducting preclinical and clinical trials, and refining manufacturing for market release.
Explore how bioinformatics merges information technology with biotechnology to manage and analyze vast biological data. Learn how data assembly and analysis enable protein structure prediction, disease insights, and drug development.
Explore biotechnology applications across green, white, and red sectors, from drugs and enzymes to agricultural products and research services like drug discovery and manufacturing, under regulatory and market constraints.
Explore how biotechnology targets disease through drugs, monoclonal antibodies, RNA interference, and gene therapy, and examine diagnostics, personalized medicine, tissue engineering, stem cells, and xenotransplantation.
Learn the business of biotechnology, how to start and manage biotechnology companies, and how to better service the needs of biotechnology companies.
Going beyond simple 'science for non-scientists' or 'mini MBA' offerings, this course describes the convergence of scientific, political, regulatory, and commercial factors that drive the biotechnology industry and define its scope.
Topics covered include:
The development of biotechnology
An accessible introduction to the science of biotechnology
Drug development
Laws, Regulations, and Policy
Intellectual Property
Patents
The Business of Biotechnology
Finance
Marketing
Management
This course is based on the leading business-of-biotechnology text, "Building Biotechnology," which has been adopted by more than 50 schools, and is taught by Yali Friedman, Ph.D., publisher of the Journal of Commercial Biotechnology and a former instructor of biotechnology management at the National Institutes of Health.
I hope you enjoy this course as much as I did putting it together.
For those interested in drug development specifically, you can also check out my other Udemy Course: Generic Drug Entry & Branded Drug Lifecycle Management
About the Author:
Yali Friedman, Ph.D. has more than 20 years experience providing business intelligence to life science companies. He was recently named one of the 100 most influential people in biotechnology by Scientific American. He is also author of the MBA-level textbook Building Biotechnology and publisher of the Journal of Commercial Biotechnology.